Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

"It's an Uphill Battle. We Have a Long Way to Go": Perspectives of Canadian Individuals Living with Genetic Conditions Detectable by Prenatal Cell-Free DNA Screening.

AJOB empirical bioethics·2026
Same author

Enrichment of fetal cell-free DNA in early miscarriages for detection of aneuploidy: a novel approach.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC·2026
Same author

Predicting Functional Decline in Duchenne Muscular Dystrophy: Advancing Trial Readiness and Patient Counseling.

Neurology·2026
Same author

Vamorolone Safety, Pharmacokinetics, and Exploratory Efficacy in Duchenne Muscular Dystrophy: A Phase II, Nonrandomized, Multiple-Dose Study in 2-<4-Year-Old Boys.

Neurology·2026
Same author

How variants of uncertain significance affect clinical decisions: A systematic review.

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same author

A Comparison of Preeclampsia Screening Using Clinical Risk Factors and the Fetal Medicine Foundation Algorithm.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC·2026
Same journal

Health Outcomes of Patients with Distal Urea Cycle Disorders Detected by Newborn Screening: Data from the Spanish National Registry.

International journal of neonatal screening·2026
Same journal

Ethical and Clinical Boundaries in Genomics & Newborn Screening: A Brief Report from IPIC2025.

International journal of neonatal screening·2026
Same journal

Implementation of a Prospective Birth Cohort for Newborn Screening and Early Linkage to Comprehensive Sickle Cell Disease Care in a Low-Resource Setting.

International journal of neonatal screening·2026
Same journal

Transitioning from Laboratory-Developed Tests to a Single Commercial Reagent Kit in a National Newborn Screening Program: Impact on Analytical Performance and Harmonization.

International journal of neonatal screening·2026
Same journal

Development of Dried Blood Spot Proficiency Testing Materials for Newborn Screening of Lysosomal Diseases Using Recombinant Enzymes.

International journal of neonatal screening·2026
Same journal

A Four-Year Prospective Pilot Study of Newborn Screening for Late-Onset Proximal Urea-Cycle Disorders in Hyogo Prefecture in Japan.

International journal of neonatal screening·2026
See all related articles

Related Experiment Video

Updated: Jan 14, 2026

A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy
10:02

A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy

Published on: November 3, 2016

25.4K

Quebec Spinal Muscular Atrophy Newborn Screening Program: The First Year Experience.

Emilie Groulx-Boivin1,2, Ariane Belzile2, Cam-Tu Émilie Nguyen3

  • 1Departments of Pediatrics and Neurology & Neurosurgery, Montreal Children's Hospital, McGill University, Montreal, QC H4A 3H9, Canada.

International Journal of Neonatal Screening
|October 24, 2025
PubMed
Summary
This summary is machine-generated.

Quebec's newborn screening for spinal muscular atrophy (SMA) identified affected infants early, enabling prompt treatment and improving motor outcomes. The program established the provincial SMA birth prevalence, highlighting the need for faster sample processing.

Keywords:
CanadaSMN2genetic disordernewborn screeningpediatricspinal muscular atrophy

More Related Videos

Assessment of the Efficacy of An Osteopathic Treatment in Infants with Biomechanical Impairments to Suckling
07:11

Assessment of the Efficacy of An Osteopathic Treatment in Infants with Biomechanical Impairments to Suckling

Published on: February 5, 2019

9.6K
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

87.5K

Related Experiment Videos

Last Updated: Jan 14, 2026

A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy
10:02

A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy

Published on: November 3, 2016

25.4K
Assessment of the Efficacy of An Osteopathic Treatment in Infants with Biomechanical Impairments to Suckling
07:11

Assessment of the Efficacy of An Osteopathic Treatment in Infants with Biomechanical Impairments to Suckling

Published on: February 5, 2019

9.6K
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

87.5K

Area of Science:

  • Genetics
  • Neurology
  • Public Health

Background:

  • Early treatment of spinal muscular atrophy (SMA) significantly improves clinical outcomes.
  • Newborn screening (NBS) for SMA is increasingly implemented globally due to treatment advancements.
  • The province of Quebec initiated its SMA NBS program in October 2023.

Purpose of the Study:

  • To evaluate the first-year experience of the Quebec SMA NBS program.
  • To determine the screening yield and birth prevalence of SMA in Quebec.
  • To assess clinical outcomes and identify challenges in the program's initial phase.

Main Methods:

  • Prospective analysis of newborns screened through the Quebec SMA NBS program over its first year.
  • Confirmation of positive screening results through diagnostic testing.
  • Tracking of clinical presentation, SMN2 copy number, treatment initiation, and motor outcomes.

Main Results:

  • Six newborns screened positive for SMA out of 67,933 screened infants.
  • Provincial birth prevalence of SMA was estimated at 1 in 9705 live births.
  • Treated infants showed stable or improved motor function at 3-6 months; however, one symptomatic infant with two SMN2 copies died.

Conclusions:

  • The Quebec SMA NBS pilot program successfully identified newborns with SMA and facilitated early treatment.
  • The program provided the first provincial estimate of SMA birth prevalence.
  • Enhancing sample shipping and processing times is crucial for maximizing the program's impact.